Finance

Lists
260660:KOSDAQ
Korea Arlico Pharm Co Ltd
â‚©2,160.00
-1.14%
(-25.00) 1D
Oct 20, 3:30:24 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 260660...
Open
â‚©2,150
High
â‚©2,200
Low
â‚©2,130
Mkt. cap
33.11B
Avg. vol.
64.67K
Volume
10.17K
Dividend
3.47%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©5,760
52-wk low
â‚©2,055
EPS
-â‚©190
Shares outstanding
15.33M
No. of employees
218
Open
â‚©2,150
High
â‚©2,200
Low
â‚©2,130
Mkt. cap
33.11B
Avg. vol.
64.67K
Volume
10.17K
Dividend
3.47%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©5,760
52-wk low
â‚©2,055
EPS
-â‚©190
Shares outstanding
15.33M
No. of employees
218
News stories
From web sources and news partners
About Korea Arlico Pharm Co Ltd
CEO-
Employees218
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
52.20B
48.33B
48.32B
46.85B
Cost of goods sold
26.03B
23.53B
22.03B
24.43B
Cost of revenue
26.03B
23.53B
22.03B
24.43B
Research and development expenses
2.52B
654.07M
2.21B
1.25B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.16B
25.83B
24.81B
25.40B
Operating expense
26.17B
26.48B
28.05B
26.99B
Total operating expenses
52.20B
50.01B
50.08B
51.43B
Operating income
4.03M
-1.69B
-1.76B
-4.57B
Other non operating income
-360.93M
1.87B
966.39M
1.19B
EBT including unusual items
-356.90M
-1.79B
-795.59M
-3.38B
EBT excluding unusual items
-356.90M
-1.82B
-795.59M
-3.38B
Income tax expense
196.85M
-809.31M
-174.99M
-2.69B
Effective tax rate
-55.15%
45.15%
22.00%
79.49%
Other operating expenses
77.76M
27.07M
107.82M
32.08M
Net income
-553.75M
-983.35M
-620.60M
-693.57M
Net profit margin
-1.06%
-2.03%
-1.28%
-1.48%
Earnings per share
-
-
-
-
Interest and investment income
-
230.21M
-
-
Interest expense
-
-2.16B
-
-
Net interest expenses
-
-1.93B
-
-
Depreciation and amortization charges
262.11M
-261.66M
83.46M
77.32M
EBITDA
1.19B
-362.79M
-517.53M
-3.32B
Gain or loss from assets sale
-69.74M
-6.26M
-
6.00K
AI content may include mistakes. Learn more
Google apps